LeMaitre Vascular Key Executives
This section highlights LeMaitre Vascular's key executives, including their titles and compensation details.
Find Contacts at LeMaitre Vascular
(Showing 0 of )
LeMaitre Vascular Earnings
This section highlights LeMaitre Vascular's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-27 | $0.49 | $0.49 |
| Read Transcript | Q3 | 2024 | 2024-10-31 | $0.44 | $0.49 |
| Read Transcript | Q2 | 2024 | 2024-08-01 | $0.47 | $0.52 |
| Read Transcript | Q1 | 2024 | 2024-05-09 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-02-27 | $0.36 | $0.38 |
| Read Transcript | Q3 | 2023 | 2023-11-01 | $0.30 | $0.33 |
| Read Transcript | Q2 | 2023 | 2023-08-01 | $0.32 | $0.36 |
| Read Transcript | Q1 | 2023 | 2023-05-02 | $0.25 | $0.27 |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
$91.54
Stock Price
$2.07B
Market Cap
664
Employees
Burlington, MA
Location
Financial Statements
Access annual & quarterly financial statements for LeMaitre Vascular, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $219.86M | $193.48M | $161.65M | $154.42M | $129.37M |
| Cost of Revenue | $68.96M | $66.44M | $56.76M | $53.04M | $44.75M |
| Gross Profit | $150.90M | $127.05M | $104.90M | $101.38M | $84.62M |
| Gross Profit Ratio | 68.63% | 65.66% | 64.89% | 65.65% | 65.41% |
| Research and Development Expenses | $15.65M | $16.97M | $13.29M | $11.80M | $10.10M |
| General and Administrative Expenses | $36.26M | $31.83M | $28.75M | $25.50M | $22.50M |
| Selling and Marketing Expenses | $46.74M | $41.05M | $32.92M | $27.66M | $23.70M |
| Selling General and Administrative Expenses | $83.00M | $72.89M | $61.67M | $53.16M | $46.20M |
| Other Expenses | $- | $485.00K | $-325.00K | $-116.00K | $-122.00K |
| Operating Expenses | $98.64M | $90.34M | $74.96M | $64.96M | $56.30M |
| Cost and Expenses | $167.61M | $156.77M | $131.72M | $118.00M | $101.05M |
| Interest Income | $4.95M | $3.08M | $986.00K | $197.00K | $207.00K |
| Interest Expense | $205.00K | $- | $986.00K | $2.22M | $1.31M |
| Depreciation and Amortization | $9.67M | $9.52M | $9.43M | $9.47M | $8.22M |
| EBITDA | $66.75M | $48.99M | $36.92M | $45.98M | $36.89M |
| EBITDA Ratio | 30.36% | 25.32% | 22.84% | 29.78% | 28.52% |
| Operating Income | $52.26M | $36.71M | $21.16M | $25.55M | $19.80M |
| Operating Income Ratio | 23.77% | 18.97% | 13.09% | 16.55% | 15.31% |
| Total Other Income Expenses Net | $4.62M | $2.76M | $661.00K | $-2.14M | $-1.43M |
| Income Before Tax | $56.88M | $39.48M | $27.49M | $34.29M | $27.36M |
| Income Before Tax Ratio | 25.87% | 20.40% | 17.01% | 22.20% | 21.15% |
| Income Tax Expense | $12.84M | $9.37M | $6.85M | $7.38M | $6.14M |
| Net Income | $44.04M | $30.11M | $20.64M | $26.91M | $21.22M |
| Net Income Ratio | 20.03% | 15.56% | 12.77% | 17.42% | 16.40% |
| EPS | $1.96 | $1.36 | $0.94 | $1.27 | $1.05 |
| EPS Diluted | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 |
| Weighted Average Shares Outstanding | 22.45M | 22.22M | 21.98M | 21.16M | 20.25M |
| Weighted Average Shares Outstanding Diluted | 22.78M | 22.42M | 22.17M | 21.48M | 20.48M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55.72M | $54.82M | $55.85M | $53.48M | $48.88M | $47.41M | $50.12M | $47.08M | $40.95M | $39.03M | $42.11M | $39.56M | $39.50M | $38.37M | $40.67M | $35.88M | $37.55M | $36.42M | $24.85M | $30.55M |
| Cost of Revenue | $17.13M | $17.64M | $18.85M | $16.81M | $17.11M | $16.60M | $18.03M | $16.19M | $14.90M | $13.96M | $14.30M | $13.60M | $13.55M | $13.50M | $13.91M | $12.08M | $13.15M | $13.71M | $7.82M | $10.07M |
| Gross Profit | $38.59M | $37.18M | $37.00M | $36.66M | $31.78M | $30.82M | $32.09M | $30.88M | $26.05M | $25.07M | $27.81M | $25.96M | $25.96M | $24.87M | $26.76M | $23.80M | $24.40M | $22.70M | $17.03M | $20.48M |
| Gross Profit Ratio | 69.26% | 67.82% | 66.24% | 68.56% | 65.01% | 65.00% | 64.02% | 65.60% | 63.62% | 64.24% | 66.04% | 65.63% | 65.71% | 64.81% | 65.80% | 66.32% | 64.99% | 62.35% | 68.52% | 67.05% |
| Research and Development Expenses | $3.62M | $3.66M | $4.28M | $4.09M | $4.35M | $4.22M | $4.52M | $3.88M | $3.55M | $3.46M | $3.35M | $2.93M | $3.46M | $2.85M | $2.65M | $2.84M | $2.87M | $2.10M | $2.14M | $2.99M |
| General and Administrative Expenses | $9.49M | $8.93M | $8.82M | $9.01M | $8.44M | $7.74M | $7.72M | $7.93M | $6.93M | $7.23M | $7.33M | $7.25M | $6.75M | $6.00M | $6.20M | $6.54M | $6.08M | $5.90M | $5.33M | $5.19M |
| Selling and Marketing Expenses | $12.63M | $11.44M | $10.98M | $11.69M | $10.27M | $9.67M | $10.22M | $10.90M | $8.60M | $8.23M | $8.24M | $7.85M | $7.45M | $6.94M | $6.80M | $6.47M | $5.91M | $5.16M | $4.69M | $7.95M |
| Selling General and Administrative Expenses | $22.12M | $20.37M | $18.33M | $20.70M | $17.27M | $17.41M | $17.94M | $18.83M | $15.53M | $15.46M | $15.57M | $15.10M | $14.20M | $12.95M | $13.00M | $13.01M | $11.99M | $11.06M | $10.02M | $13.14M |
| Other Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $384.00K | $- | $- | $- | $- | $- | $- | $- | $-35.00K | $25.00K | $-105.00K | $-73.00K |
| Operating Expenses | $25.74M | $24.03M | $22.62M | $24.79M | $21.62M | $21.64M | $22.45M | $22.70M | $19.09M | $18.92M | $18.92M | $18.03M | $17.66M | $15.79M | $15.65M | $15.85M | $14.86M | $13.16M | $12.16M | $16.13M |
| Cost and Expenses | $42.86M | $41.67M | $41.47M | $41.60M | $38.73M | $38.23M | $40.48M | $38.90M | $33.99M | $32.88M | $33.22M | $31.63M | $31.20M | $29.30M | $29.56M | $27.94M | $28.00M | $26.87M | $19.98M | $26.20M |
| Interest Income | $1.61M | $1.20M | $1.14M | $1.00M | $992.00K | $835.00K | $682.00K | $568.00K | $447.00K | $264.00K | $167.00K | $108.00K | $141.00K | $54.00K | $1.00K | $1.00K | $13.00K | $15.00K | $74.00K | $105.00K |
| Interest Expense | $205.00K | $- | $- | $- | $143.00K | $- | $- | $- | $447.00K | $264.00K | $167.00K | $108.00K | $526.00K | $621.00K | $495.00K | $577.00K | $579.00K | $665.00K | $66.00K | $- |
| Depreciation and Amortization | $2.48M | $2.43M | $2.38M | $2.38M | $2.44M | $2.40M | $2.33M | $2.35M | $2.29M | $2.33M | $2.44M | $2.37M | $2.88M | $2.92M | $2.87M | $2.62M | $2.53M | $2.68M | $1.64M | $1.54M |
| EBITDA | $20.16M | $15.57M | $16.76M | $14.26M | $13.76M | $11.57M | $11.96M | $10.53M | $10.09M | $8.48M | $11.34M | $10.30M | $11.31M | $11.98M | $13.82M | $10.69M | $12.04M | $12.73M | $6.47M | $5.82M |
| EBITDA Ratio | 36.18% | 28.41% | 30.02% | 26.66% | 28.14% | 24.41% | 23.86% | 22.37% | 24.63% | 21.72% | 26.92% | 26.04% | 28.64% | 31.22% | 33.99% | 29.80% | 32.08% | 34.95% | 26.04% | 19.04% |
| Operating Income | $12.85M | $13.15M | $14.38M | $11.87M | $10.15M | $9.18M | $9.45M | $7.87M | $5.51M | $4.09M | $5.78M | $5.66M | $8.30M | $9.07M | $11.11M | $7.95M | $9.54M | $10.02M | $4.87M | $4.35M |
| Operating Income Ratio | 23.07% | 23.98% | 25.75% | 22.20% | 20.77% | 19.36% | 18.86% | 16.73% | 13.45% | 10.47% | 13.74% | 14.31% | 21.01% | 23.65% | 27.31% | 22.14% | 25.42% | 27.51% | 19.60% | 14.25% |
| Total Other Income Expenses Net | $1.17M | $1.40M | $1.13M | $923.00K | $1.11M | $646.00K | $867.00K | $143.00K | $831.00K | $-2.00K | $-236.00K | $68.00K | $-396.00K | $-639.00K | $-651.00K | $-452.00K | $-614.00K | $-640.00K | $-105.00K | $-73.00K |
| Income Before Tax | $14.02M | $14.55M | $15.51M | $12.80M | $11.31M | $9.83M | $10.32M | $8.02M | $7.80M | $6.15M | $5.55M | $8.00M | $7.91M | $8.43M | $10.46M | $7.49M | $8.93M | $9.38M | $4.77M | $4.28M |
| Income Before Tax Ratio | 25.16% | 26.54% | 27.76% | 23.93% | 23.14% | 20.73% | 20.59% | 17.03% | 19.04% | 15.75% | 13.18% | 20.21% | 20.01% | 21.98% | 25.71% | 20.88% | 23.79% | 25.75% | 19.18% | 14.01% |
| Income Tax Expense | $2.84M | $3.41M | $3.68M | $2.91M | $2.85M | $2.32M | $2.22M | $1.98M | $2.17M | $692.00K | $2.03M | $1.96M | $1.73M | $1.93M | $2.16M | $1.56M | $1.90M | $1.86M | $1.27M | $1.11M |
| Net Income | $11.18M | $11.14M | $11.83M | $9.89M | $8.46M | $7.50M | $8.10M | $6.04M | $5.63M | $5.46M | $3.52M | $6.04M | $6.17M | $6.50M | $8.30M | $5.93M | $7.03M | $7.51M | $3.50M | $3.17M |
| Net Income Ratio | 20.07% | 20.32% | 21.17% | 18.49% | 17.32% | 15.82% | 16.16% | 12.83% | 13.74% | 13.98% | 8.35% | 15.26% | 15.63% | 16.95% | 20.41% | 16.52% | 18.73% | 20.63% | 14.08% | 10.39% |
| EPS | $0.50 | $0.50 | $0.53 | $0.44 | $0.38 | $0.34 | $0.36 | $0.27 | $0.26 | $0.25 | $0.16 | $0.28 | $0.28 | $0.30 | $0.40 | $0.29 | $0.35 | $0.37 | $0.17 | $0.16 |
| EPS Diluted | $0.49 | $0.49 | $0.52 | $0.44 | $0.38 | $0.33 | $0.36 | $0.27 | $0.25 | $0.25 | $0.16 | $0.27 | $0.28 | $0.30 | $0.40 | $0.28 | $0.34 | $0.37 | $0.17 | $0.16 |
| Weighted Average Shares Outstanding | 22.51M | 22.48M | 22.46M | 22.36M | 22.28M | 22.26M | 22.21M | 22.11M | 22.02M | 21.98M | 21.96M | 21.93M | 21.86M | 21.59M | 20.61M | 20.55M | 20.38M | 20.25M | 20.18M | 20.17M |
| Weighted Average Shares Outstanding Diluted | 22.90M | 22.84M | 22.73M | 22.57M | 22.46M | 22.48M | 22.45M | 22.27M | 22.24M | 22.22M | 22.13M | 22.10M | 22.14M | 21.93M | 20.96M | 20.85M | 20.62M | 20.47M | 20.40M | 20.44M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $25.61M | $24.27M | $19.13M | $13.86M | $26.76M |
| Short Term Investments | $274.11M | $80.81M | $63.56M | $56.10M | $214.00K |
| Cash and Short Term Investments | $299.72M | $105.07M | $82.69M | $69.96M | $26.98M |
| Net Receivables | $30.06M | $25.06M | $22.04M | $19.63M | $19.55M |
| Inventory | $64.93M | $52.33M | $50.27M | $46.10M | $45.12M |
| Other Current Assets | $7.48M | $12.13M | $6.73M | $8.38M | $5.24M |
| Total Current Assets | $402.19M | $194.60M | $161.73M | $139.88M | $94.26M |
| Property Plant Equipment Net | $41.57M | $39.78M | $33.53M | $32.13M | $31.10M |
| Goodwill | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M |
| Intangible Assets | $35.82M | $41.71M | $46.53M | $52.71M | $58.91M |
| Goodwill and Intangible Assets | $101.76M | $107.66M | $112.47M | $118.66M | $124.85M |
| Long Term Investments | $- | $- | $- | $- | $- |
| Tax Assets | $1.43M | $1.00M | $1.75M | $1.57M | $1.69M |
| Other Non-Current Assets | $4.87M | $3.74M | $991.00K | $568.00K | $909.00K |
| Total Non-Current Assets | $149.62M | $152.18M | $148.74M | $152.92M | $158.55M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $551.82M | $346.78M | $310.48M | $292.80M | $252.81M |
| Account Payables | $1.76M | $3.73M | $2.90M | $2.34M | $2.39M |
| Short Term Debt | $2.68M | $2.47M | $3.77M | $3.74M | $6.41M |
| Tax Payables | $15.76M | $390.00K | $11.22M | $10.79M | $11.07M |
| Deferred Revenue | $- | $- | $- | $16.33M | $17.52M |
| Other Current Liabilities | $10.41M | $23.28M | $7.43M | $4.95M | $5.27M |
| Total Current Liabilities | $30.61M | $29.88M | $25.33M | $21.81M | $25.14M |
| Long Term Debt | $183.00M | $16.62M | $29.42M | $28.13M | $50.32M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $85.00K | $107.00K | $69.00K | $70.00K | $127.00K |
| Other Non-Current Liabilities | $831.00K | $2.27M | $-12.54M | $-11.37M | $4.64M |
| Total Non-Current Liabilities | $183.92M | $19.00M | $16.95M | $16.84M | $55.09M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $214.53M | $48.88M | $42.27M | $38.65M | $80.24M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $242.00K | $239.00K | $237.00K | $235.00K | $221.00K |
| Retained Earnings | $145.09M | $115.43M | $97.77M | $88.12M | $70.55M |
| Accumulated Other Comprehensive Income Loss | $-6.18M | $-4.62M | $-6.03M | $-3.44M | $-1.52M |
| Other Total Stockholders Equity | $198.14M | $186.86M | $176.22M | $169.23M | $103.32M |
| Total Stockholders Equity | $337.29M | $297.90M | $268.20M | $254.15M | $172.57M |
| Total Equity | $337.29M | $297.90M | $268.20M | $254.15M | $172.57M |
| Total Liabilities and Stockholders Equity | $551.82M | $346.78M | $310.48M | $292.80M | $252.81M |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $551.82M | $346.78M | $310.48M | $292.80M | $252.81M |
| Total Investments | $274.11M | $80.81M | $63.56M | $56.10M | $214.00K |
| Total Debt | $185.69M | $19.09M | $16.60M | $15.94M | $54.78M |
| Net Debt | $160.07M | $-5.17M | $-2.54M | $2.08M | $28.01M |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $25.61M | $21.00M | $22.27M | $26.59M | $24.27M | $18.05M | $19.49M | $16.68M | $19.13M | $16.91M | $20.79M | $15.56M | $13.86M | $17.37M | $21.54M | $23.52M | $26.76M | $29.28M | $19.98M | $10.94M |
| Short Term Investments | $274.11M | $102.89M | $90.83M | $81.69M | $80.81M | $78.97M | $70.69M | $64.33M | $63.56M | $62.83M | $54.90M | $55.32M | $56.10M | $49.71M | $215.00K | $214.00K | $214.00K | $5.10M | $5.07M | $19.69M |
| Cash and Short Term Investments | $299.72M | $123.89M | $113.10M | $108.29M | $105.07M | $97.02M | $90.18M | $81.00M | $82.69M | $79.74M | $75.68M | $70.88M | $69.96M | $67.08M | $21.76M | $23.74M | $26.98M | $34.38M | $25.05M | $30.63M |
| Net Receivables | $30.06M | $32.27M | $30.82M | $30.24M | $25.06M | $23.88M | $26.41M | $25.36M | $22.04M | $20.09M | $21.54M | $21.39M | $19.63M | $19.50M | $20.74M | $20.13M | $19.55M | $19.62M | $17.70M | $16.63M |
| Inventory | $55.94M | $65.02M | $56.66M | $54.49M | $52.33M | $56.19M | $53.83M | $53.78M | $50.27M | $47.71M | $47.19M | $46.66M | $46.10M | $44.33M | $44.75M | $45.07M | $45.12M | $45.64M | $46.34M | $40.58M |
| Other Current Assets | $16.46M | $5.94M | $12.23M | $9.95M | $12.13M | $5.10M | $4.08M | $4.62M | $6.73M | $10.44M | $7.31M | $4.96M | $8.38M | $6.22M | $5.54M | $3.44M | $5.24M | $5.22M | $5.57M | $3.76M |
| Total Current Assets | $402.19M | $227.12M | $205.80M | $196.88M | $188.85M | $182.18M | $174.49M | $164.77M | $161.73M | $153.14M | $148.49M | $141.41M | $139.88M | $134.02M | $90.02M | $90.66M | $94.26M | $102.25M | $91.87M | $89.72M |
| Property Plant Equipment Net | $41.57M | $41.12M | $40.41M | $39.97M | $39.78M | $37.21M | $37.02M | $34.77M | $33.53M | $31.14M | $32.04M | $31.37M | $32.13M | $32.66M | $32.04M | $30.68M | $31.10M | $30.51M | $32.42M | $29.67M |
| Goodwill | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $65.94M | $66.15M | $39.77M |
| Intangible Assets | $35.82M | $37.30M | $38.77M | $40.24M | $41.71M | $43.20M | $44.00M | $45.51M | $46.53M | $48.06M | $49.60M | $51.19M | $52.71M | $54.23M | $55.78M | $57.34M | $58.91M | $60.54M | $63.16M | $24.06M |
| Goodwill and Intangible Assets | $101.76M | $103.25M | $104.71M | $106.18M | $107.66M | $109.14M | $109.94M | $111.45M | $112.47M | $114.01M | $115.54M | $117.14M | $118.66M | $120.17M | $121.72M | $123.28M | $124.85M | $126.48M | $129.32M | $63.83M |
| Long Term Investments | $- | $- | $38.77M | $1 | $41.71M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Tax Assets | $1.43M | $1.31M | $1.03M | $828.00K | $1.00M | $2.33M | $2.08M | $1.80M | $1.75M | $2.79M | $2.37M | $1.98M | $1.57M | $1.63M | $1.65M | $1.64M | $1.69M | $1.39M | $1.09M | $1.07M |
| Other Non-Current Assets | $4.87M | $4.23M | $-27.64M | $10.10M | $-32.22M | $3.15M | $2.93M | $2.07M | $991.00K | $973.00K | $984.00K | $556.00K | $568.00K | $994.00K | $1.08M | $1.11M | $909.00K | $942.00K | $1.03M | $260.00K |
| Total Non-Current Assets | $149.62M | $149.91M | $157.28M | $157.08M | $157.93M | $151.83M | $151.98M | $150.10M | $148.74M | $148.91M | $150.94M | $151.04M | $152.92M | $155.46M | $156.49M | $156.71M | $158.55M | $159.32M | $163.85M | $94.83M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $551.82M | $377.02M | $363.08M | $353.96M | $346.78M | $334.01M | $326.47M | $314.87M | $310.48M | $302.05M | $299.43M | $292.45M | $292.80M | $289.47M | $246.50M | $247.37M | $252.81M | $261.57M | $255.72M | $184.56M |
| Account Payables | $1.76M | $1.65M | $2.00M | $3.09M | $3.73M | $4.37M | $3.52M | $3.37M | $2.90M | $2.85M | $2.84M | $2.19M | $2.34M | $3.14M | $2.06M | $2.56M | $2.39M | $2.17M | $1.24M | $1.38M |
| Short Term Debt | $2.68M | $2.72M | $5.18M | $5.06M | $4.94M | $5.50M | $4.72M | $4.11M | $3.77M | $3.66M | $3.59M | $3.74M | $3.74M | $3.80M | $6.91M | $6.45M | $6.41M | $26.86M | $30.53M | $3.41M |
| Tax Payables | $15.76M | $13.92M | $927.00K | $708.00K | $390.00K | $11.69M | $9.52M | $8.09M | $11.22M | $10.64M | $10.82M | $7.92M | $10.79M | $10.94M | $8.48M | $9.62M | $11.07M | $9.17M | $6.42M | $5.97M |
| Deferred Revenue | $- | $- | $927.00K | $708.00K | $390.00K | $21.79M | $19.33M | $- | $- | $- | $- | $- | $16.33M | $16.46M | $13.77M | $14.37M | $17.52M | $14.68M | $11.84M | $11.02M |
| Other Current Liabilities | $10.41M | $11.05M | $17.34M | $17.96M | $20.81M | $7.47M | $8.10M | $8.33M | $7.43M | $6.30M | $6.16M | $4.41M | $4.95M | $4.23M | $4.03M | $3.68M | $5.27M | $6.25M | $6.17M | $5.83M |
| Total Current Liabilities | $30.61M | $29.34M | $25.45M | $26.81M | $29.88M | $29.03M | $25.86M | $23.90M | $25.33M | $23.44M | $23.41M | $18.27M | $21.81M | $22.11M | $21.48M | $22.30M | $25.14M | $44.45M | $44.36M | $16.59M |
| Long Term Debt | $183.00M | $15.60M | $31.64M | $32.71M | $16.62M | $28.26M | $28.90M | $28.90M | $29.42M | $29.79M | $30.84M | $27.41M | $28.13M | $29.18M | $49.59M | $57.20M | $50.32M | $66.61M | $68.08M | $27.43M |
| Deferred Revenue Non-Current | $- | $- | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $85.00K | $109.00K | $104.00K | $114.00K | $107.00K | $69.00K | $72.00K | $71.00K | $69.00K | $60.00K | $64.00K | $68.00K | $70.00K | $122.00K | $125.00K | $124.00K | $127.00K | $90.00K | $1.18M | $1.18M |
| Other Non-Current Liabilities | $831.00K | $896.00K | $-13.64M | $-14.18M | $2.27M | $-11.99M | $-12.19M | $-12.17M | $-12.54M | $-12.49M | $-12.92M | $-11.08M | $-11.37M | $-10.99M | $-10.52M | $-9.79M | $4.64M | $-10.56M | $-10.53M | $-9.48M |
| Total Non-Current Liabilities | $183.92M | $16.61M | $18.10M | $18.64M | $19.00M | $16.35M | $16.79M | $16.80M | $16.95M | $17.36M | $17.99M | $16.40M | $16.84M | $18.31M | $39.19M | $47.54M | $55.09M | $56.14M | $58.73M | $19.13M |
| Other Liabilities | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $214.53M | $45.95M | $43.55M | $45.45M | $48.88M | $45.38M | $42.64M | $40.70M | $42.27M | $40.80M | $41.39M | $34.67M | $38.65M | $40.42M | $60.67M | $69.84M | $80.24M | $100.59M | $103.09M | $35.72M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $242.00K | $241.00K | $240.00K | $240.00K | $239.00K | $239.00K | $239.00K | $238.00K | $237.00K | $236.00K | $235.00K | $235.00K | $235.00K | $234.00K | $222.00K | $221.00K | $221.00K | $218.00K | $217.00K | $217.00K |
| Retained Earnings | $145.09M | $137.51M | $129.96M | $121.73M | $115.43M | $110.08M | $105.70M | $100.71M | $97.77M | $94.90M | $92.19M | $91.42M | $88.12M | $84.36M | $80.25M | $74.22M | $70.55M | $65.46M | $59.87M | $58.29M |
| Accumulated Other Comprehensive Income Loss | $-6.18M | $-3.16M | $-5.09M | $-5.56M | $-4.62M | $-6.71M | $-5.82M | $-5.57M | $-6.03M | $-8.13M | $-6.44M | $-4.62M | $-3.44M | $-2.64M | $-2.24M | $-2.46M | $-1.52M | $-3.01M | $-4.16M | $-5.53M |
| Other Total Stockholders Equity | $198.14M | $196.48M | $194.43M | $192.09M | $186.86M | $185.02M | $183.71M | $178.78M | $176.22M | $174.24M | $172.05M | $170.76M | $169.23M | $167.09M | $107.60M | $105.55M | $103.32M | $98.32M | $96.70M | $95.86M |
| Total Stockholders Equity | $337.29M | $331.07M | $319.53M | $308.50M | $297.90M | $288.64M | $283.83M | $274.17M | $268.20M | $261.25M | $258.03M | $257.79M | $254.15M | $249.05M | $185.83M | $177.53M | $172.57M | $160.98M | $152.63M | $148.84M |
| Total Equity | $337.29M | $331.07M | $319.53M | $308.50M | $297.90M | $288.64M | $283.83M | $274.17M | $268.20M | $261.25M | $258.03M | $257.79M | $254.15M | $249.05M | $185.83M | $177.53M | $172.57M | $160.98M | $152.63M | $148.84M |
| Total Liabilities and Stockholders Equity | $551.82M | $377.02M | $363.08M | $353.96M | $346.78M | $334.01M | $326.47M | $314.87M | $310.48M | $302.05M | $299.43M | $292.45M | $292.80M | $289.47M | $246.50M | $247.37M | $252.81M | $261.57M | $255.72M | $184.56M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $551.82M | $377.02M | $363.08M | $353.96M | $346.78M | $334.01M | $326.47M | $314.87M | $310.48M | $302.05M | $299.43M | $292.45M | $292.80M | $289.47M | $246.50M | $247.37M | $252.81M | $261.57M | $255.72M | $184.56M |
| Total Investments | $274.11M | $102.89M | $90.83M | $81.69M | $80.81M | $78.97M | $70.69M | $64.33M | $63.56M | $62.83M | $54.90M | $55.32M | $56.10M | $49.71M | $215.00K | $214.00K | $214.00K | $5.10M | $5.07M | $19.69M |
| Total Debt | $185.69M | $18.33M | $18.41M | $18.88M | $19.09M | $16.88M | $16.81M | $16.50M | $16.60M | $16.73M | $17.21M | $15.58M | $15.94M | $16.49M | $39.47M | $47.44M | $54.78M | $76.48M | $81.30M | $15.42M |
| Net Debt | $160.07M | $-2.67M | $-3.86M | $-7.71M | $-5.17M | $-1.17M | $-2.68M | $-172.00K | $-2.54M | $-188.00K | $-3.57M | $17.00K | $2.08M | $-879.00K | $17.93M | $23.92M | $28.01M | $47.20M | $61.33M | $4.47M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $44.04M | $30.11M | $20.64M | $26.91M | $21.22M |
| Depreciation and Amortization | $9.67M | $9.52M | $9.43M | $11.07M | $8.39M |
| Deferred Income Tax | $-451.00K | $783.00K | $-182.00K | $79.00K | $-328.00K |
| Stock Based Compensation | $6.57M | $5.32M | $4.17M | $3.48M | $3.02M |
| Change in Working Capital | $-20.10M | $-11.25M | $-13.40M | $-9.96M | $863.00K |
| Accounts Receivables | $-6.42M | $- | $-3.53M | $-818.00K | $-939.00K |
| Inventory | $-10.57M | $- | $-7.42M | $-5.49M | $-2.61M |
| Accounts Payables | $-779.00K | $4.60M | $645.00K | $-1.73M | $4.32M |
| Other Working Capital | $-2.33M | $-15.85M | $-3.10M | $-1.93M | $89.00K |
| Other Non Cash Items | $4.40M | $2.28M | $4.72M | $3.53M | $1.63M |
| Net Cash Provided by Operating Activities | $44.12M | $36.75M | $25.38M | $35.10M | $34.80M |
| Investments in Property Plant and Equipment | $-6.96M | $-7.26M | $-3.23M | $-4.88M | $-2.98M |
| Acquisitions Net | $- | $-899.00K | $858.00K | $56.19M | $-72.63M |
| Purchases of Investments | $-277.94M | $- | $-8.00M | $-59.19M | $-2.21M |
| Sales Maturities of Investments | $84.78M | $- | $-858.00K | $3.00M | $22.90M |
| Other Investing Activities | $- | $-16.55M | $858.00K | $-56.19M | $2.02M |
| Net Cash Used for Investing Activities | $-200.12M | $-24.71M | $-10.37M | $-61.08M | $-52.89M |
| Debt Repayment | $169.27M | $- | $- | $-39.00M | $39.00M |
| Common Stock Issued | $6.44M | $6.17M | $3.47M | $63.24M | $5.97M |
| Common Stock Repurchased | $- | $-853.00K | $-642.00K | $-802.00K | $-570.00K |
| Dividends Paid | $-14.38M | $-12.45M | $-10.99M | $-9.34M | $-7.70M |
| Other Financing Activities | $-3.23M | $-853.00K | $-1.71M | $-1.20M | $-4.55M |
| Net Cash Used Provided by Financing Activities | $158.10M | $-7.13M | $-9.23M | $13.70M | $32.16M |
| Effect of Forex Changes on Cash | $-765.00K | $230.00K | $-494.00K | $-637.00K | $914.00K |
| Net Change in Cash | $1.34M | $5.13M | $5.28M | $-12.91M | $14.98M |
| Cash at End of Period | $25.61M | $24.27M | $19.13M | $13.86M | $26.76M |
| Cash at Beginning of Period | $24.27M | $19.13M | $13.86M | $26.76M | $11.79M |
| Operating Cash Flow | $44.12M | $36.75M | $25.38M | $35.10M | $34.80M |
| Capital Expenditure | $-6.96M | $-7.26M | $-3.23M | $-4.88M | $-2.98M |
| Free Cash Flow | $37.16M | $29.49M | $22.15M | $30.22M | $31.82M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $11.18M | $11.14M | $11.83M | $9.89M | $8.46M | $7.50M | $8.10M | $6.04M | $5.63M | $5.46M | $3.52M | $6.04M | $6.17M | $6.50M | $8.30M | $5.93M | $7.03M | $7.51M | $3.50M | $3.17M |
| Depreciation and Amortization | $2.48M | $2.43M | $2.38M | $2.38M | $2.44M | $2.40M | $2.33M | $2.35M | $2.29M | $2.33M | $2.44M | $2.37M | $2.88M | $2.92M | $2.64M | $2.62M | $2.53M | $2.68M | $1.64M | $1.54M |
| Deferred Income Tax | $- | $- | $- | $- | $783.00K | $700.00K | $607.00K | $- | $-182.00K | $- | $- | $- | $79.00K | $1.20M | $1.18M | $1.10M | $-328.00K | $-46.00K | $439.00K | $475.00K |
| Stock Based Compensation | $1.74M | $1.61M | $1.61M | $1.61M | $1.40M | $1.31M | $1.31M | $1.29M | $684.00K | $1.19M | $1.14M | $1.17M | $886.00K | $797.00K | $869.00K | $927.00K | $753.00K | $687.00K | $803.00K | $779.00K |
| Change in Working Capital | $-1.26M | $17.39M | $-7.52M | $-9.86M | $-2.69M | $10.00K | $-463.00K | $-8.11M | $-5.46M | $-2.34M | $-637.00K | $-4.96M | $-5.48M | $3.20M | $-3.14M | $-4.55M | $3.53M | $3.25M | $-1.08M | $-4.84M |
| Accounts Receivables | $1.02M | $-942.00K | $-743.00K | $-5.75M | $-1.06M | $2.16M | $-997.00K | $-3.24M | $-1.80M | $873.00K | $-659.00K | $-1.95M | $-393.00K | $1.06M | $-629.00K | $-857.00K | $387.00K | $-1.77M | $809.00K | $-368.00K |
| Inventory | $-1.64M | $-1.65M | $-3.75M | $-3.54M | $-2.21M | $-3.31M | $-517.00K | $-3.75M | $-2.38M | $-1.50M | $-2.27M | $-1.27M | $-2.73M | $-708.00K | $-698.00K | $-1.35M | $619.00K | $848.00K | $-2.21M | $-1.86M |
| Accounts Payables | $1.76M | $1.80M | $-1.54M | $-2.79M | $2.35M | $3.24M | $1.35M | $-2.34M | $469.00K | $35.00K | $3.58M | $-3.44M | $-1.17M | $4.04M | $-1.62M | $-2.98M | $2.47M | $3.94M | $1.18M | $-3.27M |
| Other Working Capital | $-2.40M | $18.18M | $-1.49M | $2.22M | $-1.76M | $-2.08M | $-302.00K | $9.34M | $-1.75M | $-1.75M | $-1.29M | $1.69M | $-1.19M | $-1.19M | $-191.00K | $638.00K | $54.00K | $232.00K | $-856.00K | $659.00K |
| Other Non Cash Items | $1.04M | $-18.32M | $13.74M | $19.51M | $339.00K | $-97.00K | $23.00K | $711.00K | $1.12M | $716.00K | $2.79M | $98.00K | $511.00K | $-553.00K | $52.00K | $47.00K | $628.00K | $19.00K | $49.00K | $64.00K |
| Net Cash Provided by Operating Activities | $15.18M | $14.25M | $9.62M | $5.07M | $10.75M | $11.82M | $11.90M | $2.28M | $4.08M | $7.34M | $9.25M | $4.71M | $5.06M | $14.07M | $9.90M | $6.07M | $14.15M | $14.11M | $5.35M | $1.19M |
| Investments in Property Plant and Equipment | $-2.04M | $-1.67M | $-1.88M | $-1.37M | $-1.28M | $-1.05M | $-2.80M | $-2.13M | $-1.26M | $-460.00K | $-973.00K | $-536.00K | $-606.00K | $-1.81M | $-1.40M | $-1.06M | $-1.22M | $-593.00K | $-311.00K | $-863.00K |
| Acquisitions Net | $- | $- | $- | $- | $899.00K | $-468.00K | $-161.00K | $-270.00K | $858.00K | $- | $- | $- | $-49.55M | $- | $- | $- | $72.63M | $-68.00K | $-72.50M | $-59.00K |
| Purchases of Investments | $-256.63M | $-11.19M | $-9.12M | $-991.00K | $-982.00K | $-8.33M | $-6.67M | $-564.00K | $-8.00M | $-8.00M | $- | $- | $-9.64M | $-49.55M | $1.00K | $-1.00K | $-12.00K | $-15.00K | $-75.00K | $-2.10M |
| Sales Maturities of Investments | $- | $- | $- | $- | $-18.03M | $8.80M | $6.84M | $2.40M | $-858.00K | $- | $- | $- | $3.00M | $- | $- | $- | $4.90M | $- | $15.00M | $3.00M |
| Other Investing Activities | $84.78M | $- | $- | $-991.00K | $-982.00K | $-8.80M | $-6.84M | $-2.40M | $8.86M | $-8.00M | $- | $-536.00K | $49.55M | $-49.55M | $1.00K | $-1.00K | $-72.63M | $2.02M | $14.93M | $897.00K |
| Net Cash Used for Investing Activities | $-173.89M | $-12.86M | $-11.00M | $-2.36M | $-2.26M | $-9.85M | $-9.64M | $-2.96M | $-402.00K | $-8.46M | $-973.00K | $-536.00K | $-7.25M | $-51.37M | $-1.40M | $-1.06M | $3.67M | $1.35M | $-57.89M | $-25.00K |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-23.00M | $-9.00M | $-7.00M | $-21.50M | $-4.50M | $65.00M | $- |
| Common Stock Issued | $- | $-4.72M | $730.00K | $3.99M | $1.10M | $- | $3.63M | $1.45M | $1.79M | $1.01M | $164.00K | $508.00K | $1.68M | $59.45M | $728.00K | $- | $4.53M | $1.16M | $43.00K | $233.00K |
| Common Stock Repurchased | $- | $365.00K | $-7.00K | $-358.00K | $-667.00K | $-5.00K | $-9.00K | $-172.00K | $-490.00K | $-3.00K | $-4.00K | $-145.00K | $-428.00K | $-286.00K | $- | $-88.00K | $-279.00K | $-234.00K | $- | $-57.00K |
| Dividends Paid | $-3.60M | $-3.60M | $-3.59M | $-3.59M | $-3.12M | $-3.12M | $-3.12M | $-3.10M | $-2.75M | $-2.75M | $-2.75M | $-2.74M | $-2.41M | $-2.40M | $-2.27M | $-2.26M | $-1.94M | $-1.93M | $-1.92M | $-1.92M |
| Other Financing Activities | $167.68M | $448.00K | $723.00K | $3.63M | $-1.33M | $-5.00K | $3.62M | $1.27M | $-517.00K | $-404.00K | $160.00K | $363.00K | $- | $-687.00K | $-1.39M | $1.39M | $-1.82M | $-976.00K | $-1.98M | $233.00K |
| Net Cash Used Provided by Financing Activities | $164.08M | $-3.15M | $-2.87M | $39.00K | $-2.69M | $-3.12M | $502.00K | $-1.82M | $-2.12M | $-2.15M | $-2.58M | $-2.38M | $-1.16M | $33.37M | $-10.54M | $-7.96M | $-21.00M | $-6.47M | $61.38M | $-1.74M |
| Effect of Forex Changes on Cash | $-762.00K | $499.00K | $-79.00K | $-423.00K | $419.00K | $-287.00K | $45.00K | $53.00K | $668.00K | $-610.00K | $-462.00K | $-90.00K | $-165.00K | $-244.00K | $60.00K | $-288.00K | $665.00K | $318.00K | $196.00K | $-265.00K |
| Net Change in Cash | $4.61M | $-1.27M | $-4.33M | $2.33M | $6.22M | $-1.44M | $2.81M | $-2.46M | $2.22M | $-3.88M | $5.23M | $1.71M | $-3.51M | $-4.17M | $-1.98M | $-3.24M | $-2.52M | $9.30M | $9.03M | $-842.00K |
| Cash at End of Period | $25.61M | $21.00M | $22.27M | $26.59M | $24.27M | $18.05M | $19.49M | $16.68M | $19.13M | $16.91M | $20.79M | $15.56M | $13.86M | $17.37M | $21.54M | $23.52M | $26.76M | $29.28M | $19.98M | $10.94M |
| Cash at Beginning of Period | $21.00M | $22.27M | $26.59M | $24.27M | $18.05M | $19.49M | $16.68M | $19.13M | $16.91M | $20.79M | $15.56M | $13.86M | $17.37M | $21.54M | $23.52M | $26.76M | $29.28M | $19.98M | $10.94M | $11.79M |
| Operating Cash Flow | $15.18M | $14.25M | $9.62M | $5.07M | $10.75M | $11.82M | $11.90M | $2.28M | $4.08M | $7.34M | $9.25M | $4.71M | $5.06M | $14.07M | $9.90M | $6.07M | $14.15M | $14.11M | $5.35M | $1.19M |
| Capital Expenditure | $-2.04M | $-1.67M | $-1.88M | $-1.37M | $-1.28M | $-1.05M | $-2.80M | $-2.13M | $-1.26M | $-460.00K | $-973.00K | $-536.00K | $-606.00K | $-1.81M | $-1.40M | $-1.06M | $-1.22M | $-593.00K | $-311.00K | $-863.00K |
| Free Cash Flow | $13.14M | $12.58M | $7.75M | $3.70M | $9.47M | $10.77M | $9.10M | $149.00K | $2.82M | $6.88M | $8.28M | $4.17M | $4.45M | $12.26M | $8.49M | $5.01M | $12.94M | $13.52M | $5.04M | $326.00K |
LeMaitre Vascular Dividends
Explore LeMaitre Vascular's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
0.70%
Dividend Payout Ratio
32.65%
Dividend Paid & Capex Coverage Ratio
2.07x
LeMaitre Vascular Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.2 | $0.2 | March 13, 2025 | March 13, 2025 | March 27, 2025 | February 18, 2025 |
| $0.16 | $0.16 | November 21, 2024 | November 21, 2024 | December 05, 2024 | October 31, 2024 |
| $0.16 | $0.16 | August 15, 2024 | August 15, 2024 | August 29, 2024 | August 01, 2024 |
| $0.16 | $0.16 | May 15, 2024 | May 16, 2024 | May 30, 2024 | April 30, 2024 |
| $0.16 | $0.16 | March 13, 2024 | March 14, 2024 | March 28, 2024 | February 21, 2024 |
| $0.14 | $0.14 | November 15, 2023 | November 16, 2023 | November 30, 2023 | October 24, 2023 |
| $0.14 | $0.14 | August 16, 2023 | August 17, 2023 | August 31, 2023 | July 25, 2023 |
| $0.14 | $0.14 | May 16, 2023 | May 17, 2023 | June 01, 2023 | April 24, 2023 |
| $0.14 | $0.14 | March 08, 2023 | March 09, 2023 | March 23, 2023 | February 21, 2023 |
| $0.125 | $0.125 | November 16, 2022 | November 17, 2022 | December 01, 2022 | October 27, 2022 |
| $0.125 | $0.125 | August 24, 2022 | August 25, 2022 | September 08, 2022 | July 26, 2022 |
| $0.125 | $0.125 | May 16, 2022 | May 17, 2022 | June 02, 2022 | April 26, 2022 |
| $0.125 | $0.125 | March 07, 2022 | March 08, 2022 | March 24, 2022 | February 24, 2022 |
| $0.11 | $0.11 | November 18, 2021 | November 19, 2021 | December 02, 2021 | October 26, 2021 |
| $0.11 | $0.11 | August 25, 2021 | August 26, 2021 | September 09, 2021 | July 29, 2021 |
| $0.11 | $0.11 | May 18, 2021 | May 19, 2021 | June 03, 2021 | April 27, 2021 |
| $0.11 | $0.11 | March 08, 2021 | March 09, 2021 | March 25, 2021 | February 23, 2021 |
| $0.095 | $0.095 | November 18, 2020 | November 19, 2020 | December 03, 2020 | October 20, 2020 |
| $0.095 | $0.095 | August 26, 2020 | August 27, 2020 | September 10, 2020 | July 21, 2020 |
| $0.095 | $0.095 | May 19, 2020 | May 20, 2020 | June 04, 2020 | April 28, 2020 |
LeMaitre Vascular News
Read the latest news about LeMaitre Vascular, including recent articles, headlines, and updates.
The Elephant In The Room - March Dividend Income Report
I've sold some higher-yielding stocks and reduced my portfolio yield in March. The goal was to get closer to my core strategy of investing only in companies with low dividend yields, but high dividend growth potential. While my portfolio yield decreased from 4% to 3.5%, my 5-year CAGR dividend growth rate went from 8% to 11%. Despite much uncertainty, the Canadian stock market has remained relatively strong since the beginning of the year.
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Small-Cap Dividend Stocks: Hidden Gems Or High-Risk Plays? - Top U.S. And Canadian Ones
Over the past decade, the iShares S&P/TSX SmallCap Index ETF has underperformed broader markets due to its heavy exposure to resource-heavy sectors like energy and materials. Acme's dividend track record spans over 15 years, with a modest but steady payout. Debt levels remain low, and management is highly focused on operational efficiency. With regulated pricing, recurring revenue, and defensive characteristics, York Water is a favorite for income-seekers looking for small-cap stability.
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.
Stocks Falling On Earnings - What To Do? February Dividend Income Report
Alimentation Couche-Tard has several growth vectors in place with a clear 5-year plan, including organic growth and growth by acquisition. Starting in March, I will increase my Smith Manoeuvre contribution from $500 to $750 monthly. CCL Industries reported another good quarter with revenue up 9% and EPS up 5%.
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
GARDNER, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Joseph P.
When Do You Sell A Winner? - January Dividend Income Report
BlackRock is an interesting case study as I sold it for a nice profit even though the company's investment thesis is still intact. However, some metrics aren't as strong as before. I have a Telus position in one of my other portfolios. I've actively monitored its cash flow metrics. Brookfield Renewable reported another solid quarter with FFO per unit up 21%. The company's hydroelectric, wind, solar, and distributed energy businesses all contributed positively despite weaker North American hydrology affecting hydroelectric generation.
LeMaitre Vascular, Inc. (LMAT) Q4 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Nathan Treybeck - Wells Fargo Danny Stauder - Citizens JMP Matthew Park - Cantor Fitzgerald Frank Takkinen - Lake Street Capital Markets Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Operator Welcome to the LeMaitre Vascular Q4 2024 Financial Results Conference Call.
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.
The Most Underrated Mistake Destroying Your Retirement - December Dividend Income Report
Since its inception, my portfolio has been up 177%, with a 15% annualized growth rate. At this time, I'm thinking of adding a little bit more of Telus to this portfolio. The stock has been significantly penalized, while Telus' situation isn't that catastrophic (free cash flow and cash from operations improved throughout 2024). After selling Texas Instruments, the only stock I could see myself selling in 2025 would be BlackRock.
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.
LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering
BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (“LeMaitre”) (Nasdaq: LMAT) today announced its intention to offer, subject to market and other conditions, $150,000,000 aggregate principal amount of Convertible Senior Notes due 2030 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). LeMaitre also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22,500,000 aggregate principal amount of notes.
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year and double-digit CAGR over the past five years are particularly appealing. With a high-margin, low-competition niche and accelerating geographic expansion, LeMaitre remains well-positioned for sustained growth.
LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2024 Earnings Conference Call October 33, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Suraj Kalia - Oppenheimer Rick Wise - Stifel Brett Fishbin - KeyBanc Jason Wittes - Roth Danny Stauder - Citizens JMP Michael Petusky - Barrington Research Frank Takkinen - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Ross Osborn - Cantor Fritzgerald Operator Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for LMAT.